Search

Your search keyword '"Haybar H"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Haybar H" Remove constraint Author: "Haybar H"
70 results on '"Haybar H"'

Search Results

1. Atorvastatin prescription before and after Percutaneous Coronary Intervention: Effects on Left Ventricular Ejection Fraction and blood circulating Pentraxin3

2. The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography

5. Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level

7. Calprotectin Correlates with Reduced Level of LVEF and Occurrence of Cardiac Arrhythmia in STEMI Patients.

8. Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process.

9. Emerging roles of HOTAIR lncRNA in the pathogenesis and prognosis of cardiovascular diseases.

10. The prognostic potential of long noncoding RNA XIST in cardiovascular diseases: a review.

11. Cardiac Complications and COVID-19: A Review of Life-threatening Co-morbidities.

12. lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases.

13. The relationship between nut consumption and premature coronary artery disease in a representative sample of Iranians: Iran-premature coronary artery disease (IPAD) study.

14. Circular RNAs-mediated angiogenesis in human cancers.

15. Cytokines and their role in cardiovascular diseases.

16. Glycemic index, glycemic load, dietary insulin index, and dietary insulin load in relation to cardiometabolic risk factors among participants with atherosclerosis: a cross-sectional study.

18. King's Theory of Goal Attainment: Quality of Life for People With Myocardial Infarction.

19. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis.

20. The relationship between ultra processed food consumption and premature coronary artery disease: Iran premature coronary artery disease study (IPAD).

21. Ethnic differences in the lifestyle behaviors and premature coronary artery disease: a multi-center study.

22. Ethnicity based differences in statin use and hypercholesterolemia control among patients with premature coronary artery disease-results of I-PAD study.

23. Association Between Dietary Quality Indices and Atherosclerosis Risk: A Case-Control Study.

24. Impact of Obstructive Sleep Apnea Diagnosed Using the STOP-Bang Questionnaire Scale on Postoperative Complications Following Major Cardiac Surgery: A Prospective Observational Cohort Study.

25. C 2 HEST score for atrial fibrillation risk prediction models: a Diagnostic Accuracy Tests meta-analysis.

26. The association between dietary patterns with severity of coronary artery stenosis, serum leptin-to-adiponectin ratio, and some related risk factors in patients with coronary artery disease.

27. COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies.

28. [Informatori biologici per ischemia miocardica silente: approccio diagnostico e prognostico.]

29. Cardiomyopathy in Thalassemia: Quick Review from Cellular Aspects to Diagnosis and Current Treatments.

30. Expression of Blood Cells Associated CD Markers and Cardiovascular Diseases: Clinical Applications in Prognosis.

31. Relationship Between Level of Heart Type Fatty Acid Binding Protein (Before and after Procedures) with Acute Renal Failure after PCI in Patients Under PCI.

32. Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application.

33. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?

34. Strategies to inhibit arsenic trioxide-induced cardiotoxicity in acute promyelocytic leukemia.

35. Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease.

36. T-bet transcription factor in cardiovascular disease: Attenuation or inflammation factor?

37. Protective role of heat shock transcription factor 1 in heart failure: A diagnostic approach.

38. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.

39. Wnt/β-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target.

40. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease.

41. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats.

42. Development and Usability Evaluation of Web-Based Telerehabilitation Platform for Patients After Myocardial Infarction.

43. Diagnostic Value of HLA Typing in Pathogenesis of Cardiomyopathy.

44. Metformin one in a Million Efficient Medicines for Rheumatoid Arthritis Complications: Inflammation, Osteoblastogenesis, Cardiovascular Disease, Malignancies.

45. Pentraxin Level is the Key to Determine Primary Percutaneous Coronary Intervention (PCI) or Fibrinolysis.

46. Evaluation of cardiac rehabilitation on functional capacity in depressed and nondepressed patients after angioplasty.

47. Strategies to increase cardioprotection through cardioprotective chemokines in chemotherapy-induced cardiotoxicity.

48. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina.

49. What Genetics Tells us about Cardiovascular Disease in Diabetic Patients?

50. Mutations and Common Polymorphisms in ADAMTS13 and vWF Genes Responsible for Increasing Risk of Thrombosis.

Catalog

Books, media, physical & digital resources